California Genetic Testing Company Agrees to Pay $8.25 Million to Resolve False Claims Allegations; Paducah KY Area Hospital Also Settles

Agendia, Inc., a molecular diagnostics testing company based in California, has agreed to pay an $8.25 million settlement for an alleged nationwide scheme to bill Medicare for their flagship genetic test, MammaPrint, which analyzes the activity of certain genes within a breast cancer tumor to predict the risk of breast cancer recurrence in patients.